Koers Capha Pharmaceuticals Inc. Other OTC
Aandelen
FPSUF
CA13962W1086
Farmaceutische producten
Omzet 2021 | - | Omzet 2022 | - | Marktkapitalisatie | 8,87K 8,17K |
---|---|---|---|---|---|
Nettowinst (verlies) 2021 | - 0 | Nettowinst (verlies) 2022 | - 0 | EV/omzet 2021 | - |
Nettoschuld 2021 | 335K 308K | Nettoschuld 2022 | 415K 382K | EV/omzet 2022 | - |
K/w-verhouding 2021 |
-0,15
x | K/w-verhouding 2022 |
-0,12
x | Werknemers | - |
Dividendrendement 2021 * |
-
| Dividendrendement 2022 |
-
| Vrij verhandelbaar | 33,36% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
James Brown
CEO | Chief Executive Officer | - | 31-10-02 |
Janice Brown
BRD | Director/Board Member | - | 01-11-02 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
James Brown
CEO | Chief Executive Officer | - | 31-10-02 |
Janice Brown
BRD | Director/Board Member | - | 01-11-02 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+31,91% | 694 mld. | |
+29,55% | 593 mld. | |
-1,68% | 371 mld. | |
+19,29% | 331 mld. | |
+6,51% | 290 mld. | |
+14,21% | 239 mld. | |
-3,07% | 209 mld. | |
+10,03% | 209 mld. | |
+8,28% | 169 mld. |